Gastrointestinal stromal tumors (GIST) of the small bowel: High-risk pathologic features predict the need for adjuvant therapy

被引：0
|
作者：
Hassan, Imran
You, Yi-Qian N.
Shyyan, Roman
Dozois, Eric J.
Okuno, Scott H.
Smyrk, Thomas C.
Donohue, John H.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A890 / A890
页数：1
相关论文
共 50 条
  • [1] Adjuvant Therapy of Gastrointestinal Stromal Tumors (GIST)
    Paolo G. Casali
    Elena Fumagalli
    Alessandro Gronchi
    Current Treatment Options in Oncology, 2012, 13 : 277 - 284
  • [2] Adjuvant Therapy of Gastrointestinal Stromal Tumors (GIST)
    Casali, Paolo G.
    Fumagalli, Elena
    Gronchi, Alessandro
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (03) : 277 - 284
  • [3] Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world
    Toshirou Nishida
    Shinsuke Sato
    Masato Ozaka
    Yujiro Nakahara
    Yoshito Komatsu
    Masato Kondo
    Haruhiko Cho
    Seiichi Hirota
    Tatsuo Kagimura
    Yukinori Kurokawa
    Yuko Kitagawa
    Gastric Cancer, 2022, 25 : 956 - 965
  • [4] Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world
    Nishida, Toshirou
    Sato, Shinsuke
    Ozaka, Masato
    Nakahara, Yujiro
    Komatsu, Yoshito
    Kondo, Masato
    Cho, Haruhiko
    Hirota, Seiichi
    Kagimura, Tatsuo
    Kurokawa, Yukinori
    Kitagawa, Yuko
    GASTRIC CANCER, 2022, 25 (05) : 956 - 965
  • [5] The real world outcomes of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST).
    Rutkowski, Piotr
    Zietek, Marcin
    Cybulska-Stopa, Bozena
    Streb, Joanna
    Gluszek, Stanislaw
    Jankowski, Michal
    Lopacka-Szatan, Karolina
    Las-Jankowska, Manuela
    Hudziec, Piotr
    Klimczak, Anna
    Olesinski, Tomasz
    Switaj, Tomasz
    Kosela-Paterczyk, Hanna
    Bylina, Elzbieta
    Osuch, Czeslaw
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Adjuvant Therapy for High-Risk Gastrointestinal Stromal TumourConsiderations for Optimal Management
    Heikki Joensuu
    Drugs, 2012, 72 : 1953 - 1963
  • [7] Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
    Dermawan, Josephine K.
    Kelly, Ciara
    Gao, Zhidong
    Smith, Shaleigh
    Jadeja, Bhumika
    Singer, Samuel
    Tap, William D.
    Chi, Ping
    Antonescu, Cristina R.
    CLINICAL CANCER RESEARCH, 2023, 29 (19) : 3974 - 3985
  • [8] The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice
    Rutkowski, Piotr
    Zietek, Marcin
    Cybulska-Stopa, Zena
    Streb, Joanna
    Gluszek, Stanislaw
    Jankowski, Michal
    Lopacka-Szatan, Karolina
    Las-Jankowska, Manuela
    Hudziec, Piotr
    Klimczak, Anna
    Olesinski, Tomasz
    Switaj, Tomasz
    Kosela-Paterczyk, Hanna
    Bylina, Elzbieta
    Osuch, Czeslaw
    EJSO, 2021, 47 (05): : 1191 - 1195
  • [9] Gastrointestinal Stromal Tumors Risk Assessment and Adjuvant Therapy
    Joensuu, Heikki
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (05) : 889 - 904
  • [10] Adjuvant Therapy for High-Risk Gastrointestinal Stromal Tumour Considerations for Optimal Management
    Joensuu, Heikki
    DRUGS, 2012, 72 (15) : 1953 - 1963
12345